New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...

Should you forget Eli Lilly and buy this magnificent biotech instead? Let's find out.

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...